Treatment with HIV medicines is known as antiretroviral therapy. It helps to boost immunity, but there are side effects of ...

On Friday, May 9, 2025, Dr. Anatoly Dritschilo announced his resignation from the Company's Board of Directors and as Chief Scientific Officer. Additionally, Michael Vander Hoek, the Company's Vice ...

The neurofibromatosis type 1 market remains niche, but awareness campaigns, increased diagnoses, and treatment adoption, along with ongoing clinical ...

This valuable study reports the conservation of sperm-egg envelope binding by demonstrating successful recognition of the micropyle in fish eggs by the mouse sperm. However, the evidence supporting ...

General and Administrative (G&A) Expenses: G&A expenses were $9.7 million for the quarter ended March 31, 2025, compared to $10.3 million for the quarter ended March 31, 2024. The decrease was ...

ADRX-0706 has received FDA fast track designation for the treatment of metastatic or locally advanced squamous cell cervical ...

LG Chem has officially announced the launch of a diabetes treatment complex 'Jemidapa' in Thailand, and has begun to tap into ...

The trial is aimed at assessing long-term efficacy as well as safety of the therapy in 150 chronic HDV patients.

If you’re an internationally trained professional working in science, technology, engineering or math (STEM), there’s an important update you should know about: Canada’s Express Entry STEM category ...

Linerixibat, an investigational oral ileal bile acid transporter (IBAT) inhibitor, improved cholestatic pruritus in patients ...

Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of ...

Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when ...